Status: current, Not sufficiently defined by necessary conditions definition status. Date: 26-Oct 2022. Module: SNOMED CT United Kingdom drug extension module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 2089601000001116 | Belzutifan | en | Synonym | Active | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
| 2151031000001118 | Belzutifan (substance) | en | Fully specified name | Active | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Belzutifan | Is a | Antineoplastic agent | true | Inferred relationship | Existential restriction modifier |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Belzutifan 40mg tablets | Has specific active ingredient | True | Belzutifan | Inferred relationship | Existential restriction modifier | |
| Welireg 40mg tablets (Merck Sharp & Dohme (UK) Ltd) 90 tablet | Has specific active ingredient | True | Belzutifan | Inferred relationship | Existential restriction modifier | |
| Belzutifan 40mg tablets 90 tablet | Has specific active ingredient | True | Belzutifan | Inferred relationship | Existential restriction modifier | |
| Welireg 40mg tablets (Merck Sharp & Dohme (UK) Ltd) | Has specific active ingredient | True | Belzutifan | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets
FHIR